Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biorep Technologies is a medical device and engineering firm that specializes in the design and manufacture of specialized equipment for diabetes research and cell transplantation. Founded in 1994 in collaboration with the Diabetes Research Institute at the University of Miami, the company is globally recognized for developing the Ricordi Chamber, which is the gold standard for isolating pancreatic islets. Their product portfolio includes advanced perifusion systems, automated cell counters, and specialized surgical instruments used by researchers and clinicians worldwide. Beyond its own product line, Biorep provides contract engineering services, taking medical device concepts from initial design and prototyping through to full-scale manufacturing and regulatory approval. The company plays a critical role in the advancement of cell-based therapies for endocrine disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biorep Technologies.